Comac Medical, a full-service contract research organization (CRO) based in Bulgaria, has announced major leadership changes ...

A new category of diabetes, known as type 5 diabetes, has been officially recognized by the International Diabetes Federation ...

After reported discussions since February, German pharma and sciences company Merck KGaA (MRK: DE) has confirmed its ...

Belgium’s General Association of the Pharma Industry, known as pharma.de, has emphasized the importance of intellectual ...

In one of the largest all-private licensing deals so far this year, worth around 500 million euros ($569 million), ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) late Friday announced it has granted a conditional ...

Opening the door to wider treatment access and faster adoption of oral therapies for obstructive sleep apnea (OSA) and other ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) has shared new findings for TAR-200, an intravesical gemcitabine releasing ...

Seeking to ensure the quality and safety of pharmaceutical products, India's regulatory bodies have intensified their ...

US pharma major Pfizer (NYSE: PFE) reported new Phase III data over the weekend showing that its investigational PD-1 ...

Among research news last week, Gilead Sciences released positive new Phase III data on progression fee survival for its Trodelvy plus Keytruda in breast cancer. Roivant company Immunovant last week ...

US biotech giant Amgen (Nasdaq: AMGN) is the latest to build up its US base, as on Friday the company announced a $900 million expansion of its Ohio manufacturing facility, bringing the total number ...